3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders
Номер патента: ZA202103284B
Опубликовано: 25-09-2024
Автор(ы): Cota Daniela, FABRE Sandy, Maldonado Rafael, Marighetto Aline, Marsicano Giovanni, METNA Mathilde, MONLEZUN Stephanie, Ozaita Andrés, Piazza Pier-Vincenzo, Revest Jean-Michel, Vallee Monique
Принадлежит: Aelis Farma, Inst Nat Sante Rech Med, Univ Bordeaux
Опубликовано: 25-09-2024
Автор(ы): Cota Daniela, FABRE Sandy, Maldonado Rafael, Marighetto Aline, Marsicano Giovanni, METNA Mathilde, MONLEZUN Stephanie, Ozaita Andrés, Piazza Pier-Vincenzo, Revest Jean-Michel, Vallee Monique
Принадлежит: Aelis Farma, Inst Nat Sante Rech Med, Univ Bordeaux
Реферат: The present invention generally relates to a specific pregnenolone derivative for its use for the treatment of a cognitive disorders. More particularly, the invention relates to a compound of Formula (I) for its use in the treatment of cognitive disorders. Indeed, the compound of the inventionis in vivo very potent in correcting the cognitive impairments observed in cognitive disorders.
3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders
Номер патента: AU2019409912A8. Автор: Jean-Michel REVEST,Monique VALLEE,Sandy FABRE,Pier-Vincenzo Piazza,Rafael Maldonado,Mathilde Metna,Stéphanie Monlezun,Daniela Cota,Giovanni Marsicano,Andrés OZAITA,Aline MARIGHETTO. Владелец: Aelis Farma SA. Дата публикации: 2021-06-17.